immune thrombocytopenic purpura
Showing 1 - 25 of >10,000
Immune Thrombocytopenic Purpura Trial in Sohag (serum interleukin 10 level)
Not yet recruiting
- Immune Thrombocytopenic Purpura
- serum interleukin 10 level
-
Sohag, EgyptSohag University Hospital
Apr 18, 2023
Immune Thrombocytopenic Purpura Trial in Sohag (Genotyping of rs1883832C/T related single-nucleotide polymorphism)
Not yet recruiting
- Immune Thrombocytopenic Purpura
- Genotyping of rs1883832C/T related single-nucleotide polymorphism
-
Sohag, EgyptSohag University hospitals
Oct 16, 2022
COVID-19 Vaccine and Development of Immune Thrombocytopenic
Recruiting
- COVID-19 Vaccine
- covid19 vaccines
-
Assiut, EgyptEgypt
Jul 12, 2022
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
Some Cytokines Expression in ITP Primary Immune Thrombocytopenic
Recruiting
- Primary Immune Thrombocytopenia
- Plasma RNA isolation, qPCR analysis of micro RNA
- +2 more
-
Sohag, EgyptSohag University
May 7, 2022
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
T Cells and Natural Killer Cells Expression in Immune
Not yet recruiting
- Immune Thrombocytopenic Purpura
- Laboratory investigations for control
- Laboratory investigations for patients
- (no location specified)
Oct 13, 2021
Immune Thrombocytopenia Trial (VIT D)
Not yet recruiting
- Immune Thrombocytopenia
- VIT D
- (no location specified)
Oct 5, 2023
Idiopathic Thrombocytopenic Purpura Trial (Placebo, AMG 531)
Completed
- Idiopathic Thrombocytopenic Purpura
- Placebo
- AMG 531
- (no location specified)
Nov 4, 2022
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura (TTP)
- TAK-755
- (no location specified)
Feb 9, 2023
Immune Thrombocytopenic Purpura Trial in Valhalla (rituxan)
Recruiting
- Immune Thrombocytopenic Purpura
-
Valhalla, New YorkNew York Medical College
Aug 4, 2021
Caplacizumab-treated Pediatric Immune-mediated Thrombocytopenic
Active, not recruiting
- Immune-mediated Thrombocytopenic Purpura
-
Chilly-Mazarin, FranceSanofi-Aventis
Aug 8, 2022
Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenic Purpura Trial (Romiplostim)
Completed
- Idiopathic Thrombocytopenic Purpura
- +2 more
- Romiplostim
- (no location specified)
Nov 10, 2022
Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)
Recruiting
- Immune Thrombocytopenia Purpura
- Dexamethasone
- +4 more
-
Cairo, EgyptEL-Kasr elineiy
May 6, 2023
Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab
- +2 more
- (no location specified)
Aug 8, 2022
Multiple Sclerosis Trial in Los Angeles (Blood draw for future biomarker analysis)
Completed
- Multiple Sclerosis
- Blood draw for future biomarker analysis
-
Los Angeles, CaliforniaInvestigational Site Number 8400001
Mar 15, 2022
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
Immune Thrombocytopenia Trial in Hong Kong (Eltrombopag)
Suspended
- Immune Thrombocytopenia
-
Hong Kong, Hong Kong SAR, Hong KongHumanity & Health Research Centre
Mar 16, 2022
Immune Thrombocytopenic Purpura (ITP) Trial in Worldwide (Immune Globulin Intravenous (Human), 10% Triple Virally Reduced
Completed
- Immune Thrombocytopenic Purpura (ITP)
- Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
-
Brno, Czechia
- +10 more
Apr 29, 2021
Immune Thrombocytopenia Trial (peripheral blood and bone marrow withdrawal)
Not yet recruiting
- Immune Thrombocytopenia
- peripheral blood and bone marrow withdrawal
- (no location specified)
Jan 12, 2023
Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)
Enrolling by invitation
- Lupus Erythematosus, Systemic
- +3 more
- rapid GCs taper
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Aug 16, 2022
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023